Nga muốn khôi phục đối thoại với EU để thảo luận các điểm bất đồng

Ngày 4/2, Điện Kremlin tuyên bố Nga muốn khôi phục đối thoại với Liên minh châu Âu (EU) để thảo luận các điểm bất đồng trong bối cảnh Đại diện cấp cao phụ trách an ninh và Đối ngoại của EU Josep Borrell có chuyến thăm Moskva.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh